Zhijia Wang
- Oncology
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 10%
- Biomedical Engineering
- Epidemiology
- Topics
- Trigeminal Neuralgia and Treatments (5 papers)Peptidase Inhibition and Analysis (3 papers)Monoclonal and Polyclonal Antibodies Research (3 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Zhijia Wang
27 papers receiving 693 citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Oncology 195
- Molecular Biology 188
- Radiology, Nuclear Medicine and Imaging 133
- Biomedical Engineering 123
- Epidemiology 91
Countries citing papers authored by Zhijia Wang
This map shows the geographic impact of Zhijia Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhijia Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhijia Wang more than expected).
Fields of papers citing papers by Zhijia Wang
This network shows the impact of papers produced by Zhijia Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhijia Wang. The network helps show where Zhijia Wang may publish in the future.
Co-authorship network of co-authors of Zhijia Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Zhijia Wang. A scholar is included among the top collaborators of Zhijia Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhijia Wang. Zhijia Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 6 | |
| 4 | 6 | |
| 5 | 3 | |
| 6 | 2 | |
| 7 | In vivo assembly enhanced binding effect augments tumor specific ferroptosis therapybreakdown → | 67 |
| 8 | 1 | |
| 9 | Joint association of TyG index and high sensitivity C-reactive protein with cardiovascular disease: a national cohort studybreakdown → | 70 |
| 10 | 2 | |
| 11 | Triglyceride-glucose index, renal function and cardiovascular disease: a national cohort studybreakdown → | 73 |
| 12 | 4 | |
| 13 | 6 | |
| 14 | 2 | |
| 15 | 34 | |
| 16 | 18 | |
| 17 | 32 | |
| 18 | 64 | |
| 19 | 4 | |
| 20 | 5 |
About Zhijia Wang
Zhijia Wang is a scholar working on Filtration and Separation, Oncology and Pathology and Forensic Medicine, having authored 30 papers that have together received 698 indexed citations. Recurring topics across this work include Trigeminal Neuralgia and Treatments (5 papers), Peptidase Inhibition and Analysis (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Oncology (195 citations), Biomaterials (88 citations) and Radiology, Nuclear Medicine and Imaging (133 citations). Zhijia Wang has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Yuxi Wang, Hanxuan Li, Wěi Li, Lantu Gou, Yuxi Wang, Da‐Yong Hou, Wanhai Xu, Xingjie Hu, Hao Wang and Zhiyuan Wu. Their work appears in journals such as Advanced Materials, Angewandte Chemie International Edition and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.